 SVB Leerink initiated coverage on OptimizeRx Corporation NASDAQ: OPRX with a buy rating and a price target of 38, implying an upside of 36. The analysts say OptimizeRx is the largest EHR-embedded messaging network and enjoys a solid financial profile of 30 top-line growth. 